Can the interim fluorodeoxyglucose-positron emission tomography standardized uptake value be used to determine the need for residual mass biopsy after dose-dense immunochemotherapy for advanced diffuse large B-cell lymphoma? - Reply Journal Article


Authors: Moskowitz, C. H.; Zelenetz, A. D.; Schoder, H.
Article Title: Can the interim fluorodeoxyglucose-positron emission tomography standardized uptake value be used to determine the need for residual mass biopsy after dose-dense immunochemotherapy for advanced diffuse large B-cell lymphoma? - Reply
Keywords: cancer chemotherapy; clinical article; treatment outcome; prednisone; doxorubicin; rituximab; positron emission tomography; letter; carboplatin; cancer immunotherapy; multiple cycle treatment; etoposide; cyclophosphamide; vincristine; autologous stem cell transplantation; biopsy; ifosfamide; b cell lymphoma; drug uptake; large cell lymphoma; predictive value
Journal Title: Journal of Clinical Oncology
Volume: 28
Issue: 34
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2010-12-01
Start Page: e721
End Page: e722
Language: English
DOI: 10.1200/jco.2010.30.4915
PROVIDER: scopus
DOI/URL:
Notes: --- - "Export Date: 20 April 2011" - "CODEN: JCOND" - "Source: Scopus"
Altmetric Score
MSK Authors
  1. Craig Moskowitz
    373 Moskowitz
  2. Heiko Schoder
    285 Schoder
  3. Andrew D Zelenetz
    551 Zelenetz